Sanara Medtech Inc reports results for the quarter ended June 30 - Earnings Summary

• Sanara Medtech Inc SMTI.OQ reported a quarterly adjusted loss of 23 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -41 cents. The mean expectation of two analysts for the quarter was for a loss of 44 cents per share. Wall Street expected results to range from -55 cents to -33 cents per share.

• Revenue rose 28.1% to $25.83 million from a year ago; analysts expected $25.15 million.

• Sanara Medtech Inc's reported EPS for the quarter was a loss of 23 cents​.

• The company reported a quarterly loss of $2.01 million.

• Sanara Medtech Inc shares had fallen by 3.2% this quarter and lost 17.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 4.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Sanara Medtech Inc is $49.00, about 43.9% above its last closing price of $27.47

This summary was machine generated from LSEG data August 13 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)